Cancers (Mar 2022)

Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development

  • Ludovica Ceci,
  • Tianhao Zhou,
  • Ilaria Lenci,
  • Vik Meadows,
  • Lindsey Kennedy,
  • Ping Li,
  • Burcin Ekser,
  • Martina Milana,
  • Wenjun Zhang,
  • Chaodong Wu,
  • Keisaku Sato,
  • Sanjukta Chakraborty,
  • Shannon S. Glaser,
  • Heather Francis,
  • Gianfranco Alpini,
  • Leonardo Baiocchi

DOI
https://doi.org/10.3390/cancers14061442
Journal volume & issue
Vol. 14, no. 6
p. 1442

Abstract

Read online

The poor prognosis of cholangiocarcinoma in humans is related to several factors, such as (i) the heterogeneity of the disease, (ii) the late onset of symptoms and (iii) the limited comprehension of the carcinogenic pathways determining neoplastic changes, which all limit the pursuit of appropriate treatment. Several risk factors have been recognized, including different infective, immune-mediated, and dysmorphogenic disorders of the biliary tree. In this review, we report the details of possible mechanisms that lead a specific premalignant pathological condition to become cholangiocarcinoma. For instance, during liver fluke infection, factors secreted from the worms may play a major role in pathogenesis. In primary sclerosing cholangitis, deregulation of histamine and bile-acid signaling may determine important changes in cellular pathways. The study of these molecular events may also shed some light on the pathogenesis of sporadic (unrelated to risk factors) forms of cholangiocarcinoma, which represent the majority (nearly 75%) of cases.

Keywords